GMP IPO Watch
Himalaya Nutravedics India IPO Overview
Himalaya Nutravedics India IPO is currently open for subscription and is on Day 2 of bidding on September 23, 2026. The company is raising approximately ₹26.50 crore through an entirely fresh issue of 24,99,600 shares. The shares are proposed to be listed on the BSE SME platform.
| Particular | Details |
|---|---|
| IPO Name | Himalaya Nutravedics India IPO |
| IPO Type | SME Book Built |
| Price Band | ₹100–₹106 |
| Issue Size | ₹26.50 Crore |
| Fresh Issue | 24,99,600 Shares |
| Lot Size | 1,200 Shares |
| Retail Minimum | 2 Lots / 2,400 Shares |
| Minimum Investment | ₹2,54,400 |
| Open Date | September 22, 2026 |
| Close Date | September 24, 2026 |
| Allotment | September 25, 2026 |
| Refund / Demat | September 28, 2026 |
| Listing Date | September 29, 2026 |
| Listing Platform | BSE SME |
| Lead Manager | Nirbhay Capital Services |
| Registrar | KFin Technologies |
Retail investors need to apply for a minimum of two lots, or 2,400 shares. At the upper price band of ₹106, the minimum application amount is ₹2,54,400.
Himalaya Nutravedics India IPO GMP Today
The latest GMP update shows ₹0 / GMP not started for the Himalaya Nutravedics India IPO. IPO Watch reported on September 23 that no active grey-market premium had started, while another IPO tracker also showed ₹0 in its latest available update.
At a GMP of ₹0, the unofficial indicative price would remain around the upper issue price of ₹106. However, GMP is unofficial and unregulated and can change before listing, so it should not be considered a guaranteed indication of the actual listing price.
Himalaya Nutravedics India IPO Subscription Status
The IPO opened on September 22, 2026, and Day 1 ended with overall subscription of around 0.11 times. Retail investors subscribed about 0.16 times, while the NII portion was around 0.14 times. QIB bidding outside the anchor portion was reported at 0 times at the end of Day 1. Bidding continues on September 23.
The final subscription numbers will be known after the issue closes on September 24 and may change significantly during the remaining bidding period.
Himalaya Nutravedics India Business Details
Himalaya Nutravedics India Limited is an Ayurvedic and nutraceutical formulations manufacturer based in Hyderabad, Telangana. The company operates in the healthcare and wellness segment and develops and manufactures products based on Ayurvedic and nutraceutical formulations.
The company has its registered address at the Industrial Development Park in Cherlapally, Hyderabad. Its business profile is focused on the manufacturing and marketing of products in the Ayurveda and nutraceutical space.
Himalaya Nutravedics India Financial Performance
The company reported substantial growth in revenue and profitability during FY26. Total income increased from ₹21.00 crore in FY25 to ₹43.12 crore in FY26, while reported PAT increased from ₹2.23 crore to ₹7.39 crore.
| Particular | FY24 | FY25 | FY26 |
|---|---|---|---|
| Total Income | ₹14.43 Cr | ₹21.00 Cr | ₹43.12 Cr |
| EBITDA | ₹0.94 Cr | ₹2.99 Cr | ₹8.16 Cr |
| PAT | ₹0.43 Cr | ₹2.23 Cr | ₹7.39 Cr |
| EPS | ₹5.13 | ₹5.58 | ₹11.72 |
FY26 operating profit was ₹8.10 crore, while EBITDA stood at ₹8.16 crore. The increase in revenue and profit was accompanied by higher material and administrative expenses as the company's business expanded.
Himalaya Nutravedics India IPO Objects
The company plans to use a significant portion of the IPO proceeds for working capital requirements. Around ₹13.75 crore, or approximately 51.89% of the issue proceeds, is earmarked for working capital. Another ₹7.50 crore is planned for branding, digital marketing and sales expansion, with the balance intended for general corporate purposes.
The fresh capital is therefore intended to support the company's operating requirements as well as its marketing and distribution expansion.
Himalaya Nutravedics India IPO Reservation
The IPO has shares reserved across QIB, NII and retail investor categories, along with a market-maker portion.
| Investor Category | Shares Offered |
|---|---|
| QIB including Anchors | 11,84,400 |
| NII | 3,56,400 |
| Retail | 8,32,800 |
| Market Maker | 1,26,000 |
| Total | 24,99,600 |
Retail investors have at least 35% of the net offer reserved, while NII investors have at least 15%. The QIB portion can account for up to 50% of the net offer.
Himalaya Nutravedics India IPO Key Points
Himalaya Nutravedics is entering the SME market with an entirely fresh issue, giving the company access to new capital rather than an offer-for-sale component. The business has recorded strong year-on-year growth in revenue and PAT in FY26, while the IPO proceeds are primarily targeted toward working capital and sales and marketing expansion.
Investors should also consider the risks associated with a smaller SME company, including the need to successfully deploy the IPO proceeds, maintain revenue growth, manage operating costs and expand its market presence. SME-listed shares can also have different liquidity characteristics from larger mainboard companies.
Himalaya Nutravedics India IPO Important Dates
The IPO opened on September 22 and will close on September 24, 2026. The basis of allotment is expected on September 25, refunds and demat credit are scheduled for September 28, and the proposed BSE SME listing date is September 29, 2026.
Disclaimer: Himalaya Nutravedics India IPO GMP is unofficial and may change at any time. GMP does not guarantee the actual listing price or future share performance. Investors should review the company's offer documents, financial statements and associated risks before making an investment decision.
